03 Dec 2019 --- BASF Nutrition & Health is set to release its omega 3 fatty acid solution Hepacor in the European market, in collaboration with Swiss pharmaceutical company Ideogen. The solution, produced with proprietary technology, can help patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) by elevating healthy lipids in the bloodstream. Hepacor will be marketed, sold and distributed as a food supplement for special medical purposes across Switzerland through Ideogen. The Swiss launch is a European first for the product, but BASF hopes to further expand Hepacor’s footprint in Europe going forward.
